Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind multicenter study of posaconazole delayed-release tablet pulse therapy for onychomycosis
CTR20211870Phase 2Completed
- Sponsor
- XuanTai Pharmaceutical
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of posaconazole in onychomycosis, sponsored by XuanTai Pharmaceutical. Started Jan 2022; status: completed.
02
Drugs
posaconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on CTR20211870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211870.